Can I Buy Generic BiCNU?
) is a prescription medication used to treat certain brain and blood cell cancers. It belongs to a group of chemotherapy medicines known as alkylating agents.
BiCNU is made by Ben Venue Laboratories, Inc., or Emcure Pharmaceuticals, Ltd., for Bristol-Myers Squibb Company. It is an older medication, and is no longer protected by patents. However, BiCNU is not available in generic form.
When Will a Generic Version Be Available?
Because BiCNU is no longer protected by patents, a generic manufacturer could make a generic version of it. However, at this time, no generic manufacturer has chosen to do so.
It is not entirely clear why a generic version of this drug is not being made. It could be that the demand for the medicine is too small for a generic manufacturer to profit from making a generic version. Because it is unclear why a generic manufacturer has not chosen to make a generic form of BiCNU, it is difficult to predict when, or even if, a generic version will become available.
Is Carmustine a Generic BiCNU?
No -- carmustine is the active ingredient in BiCNU, but is not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent, and another company besides the original manufacturer must make the product.
Carmustine is also available as Gliadel®
). Gliadel is implanted directly into the brain to treat certain brain tumors.